Benitec Biopharma Statistics
Total Valuation
BNTC has a market cap or net worth of $264.90 million. The enterprise value is $197.27 million.
Important Dates
The next estimated earnings date is Tuesday, February 11, 2025, before market open.
| Earnings Date | Feb 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BNTC has 23.22 million shares outstanding. The number of shares has increased by 250.17% in one year.
| Current Share Class | 23.22M |
| Shares Outstanding | 23.22M |
| Shares Change (YoY) | +250.17% |
| Shares Change (QoQ) | +19.70% |
| Owned by Insiders (%) | 6.28% |
| Owned by Institutions (%) | 33.37% |
| Float | 12.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.18 |
| P/TBV Ratio | 4.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.01, with a Debt / Equity ratio of 0.00.
| Current Ratio | 15.01 |
| Quick Ratio | 14.90 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -48.23% and return on invested capital (ROIC) is -32.12%.
| Return on Equity (ROE) | -48.23% |
| Return on Assets (ROA) | -29.23% |
| Return on Capital (ROIC) | -32.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.30M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +261.08% in the last 52 weeks. The beta is 0.89, so BNTC's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +261.08% |
| 50-Day Moving Average | 10.81 |
| 200-Day Moving Average | 8.66 |
| Relative Strength Index (RSI) | 51.21 |
| Average Volume (20 Days) | 81,613 |
Short Selling Information
| Short Interest | 35,423 |
| Short Previous Month | 33,107 |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.28% |
| Short Ratio (days to cover) | 1.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | 2,000 |
| Operating Income | -22.41M |
| Pretax Income | -21.69M |
| Net Income | -20.86M |
| EBITDA | -22.31M |
| EBIT | -22.41M |
| Earnings Per Share (EPS) | -$3.37 |
Full Income StatementBalance Sheet
The company has $67.84 million in cash and $211,000 in debt, giving a net cash position of $67.63 million or $2.91 per share.
| Cash & Cash Equivalents | 67.84M |
| Total Debt | 211,000 |
| Net Cash | 67.63M |
| Net Cash Per Share | $2.91 |
| Equity (Book Value) | 64.18M |
| Book Value Per Share | 3.59 |
| Working Capital | 63.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.41 million and capital expenditures -$179,000, giving a free cash flow of -$19.59 million.
| Operating Cash Flow | -19.41M |
| Capital Expenditures | -179,000 |
| Free Cash Flow | -19.59M |
| FCF Per Share | -$0.84 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |